Agile Therapeutics, Inc.Agile Therapeutics, Inc.Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪9.69 M‬USD
−3.653100USD
‪−14.47 M‬USD
‪19.59 M‬USD
‪6.83 M‬
Beta (1Y)
−843.26

About Agile Therapeutics, Inc.

CEO
Alfred F. Altomari
Headquarters
Princeton
Employees (FY)
19
Founded
1997
FIGI
BBG013148LY0
Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patches. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.